8-95035527-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP5BP4BS2
The NM_152416.4(NDUFAF6):āc.371T>Cā(p.Ile124Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000384 in 1,613,100 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 32)
Exomes š: 0.000039 ( 2 hom. )
Consequence
NDUFAF6
NM_152416.4 missense
NM_152416.4 missense
Scores
1
8
10
Clinical Significance
Conservation
PhyloP100: 7.47
Genes affected
NDUFAF6 (HGNC:28625): (NADH:ubiquinone oxidoreductase complex assembly factor 6) This gene encodes a protein that localizes to mitochondria and contains a predicted phytoene synthase domain. The encoded protein plays an important role in the assembly of complex I (NADH-ubiquinone oxidoreductase) of the mitochondrial respiratory chain through regulation of subunit ND1 biogenesis. Mutations in this gene are associated with complex I enzymatic deficiency. [provided by RefSeq, Nov 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PP5
Variant 8-95035527-T-C is Pathogenic according to our data. Variant chr8-95035527-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 214212.We mark this variant Likely_pathogenic, oryginal submissions are: {Pathogenic=1, Uncertain_significance=3, Likely_pathogenic=1}.
BP4
Computational evidence support a benign effect (MetaRNN=0.17004153). . Strength limited to SUPPORTING due to the PP5.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151502Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
151502
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000922 AC: 23AN: 249420Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135338
GnomAD3 exomes
AF:
AC:
23
AN:
249420
Hom.:
AF XY:
AC XY:
9
AN XY:
135338
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461482Hom.: 2 Cov.: 31 AF XY: 0.0000440 AC XY: 32AN XY: 727036
GnomAD4 exome
AF:
AC:
57
AN:
1461482
Hom.:
Cov.:
31
AF XY:
AC XY:
32
AN XY:
727036
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151618Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74008
GnomAD4 genome
AF:
AC:
5
AN:
151618
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74008
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
8
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Mitochondrial complex 1 deficiency, nuclear type 17 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 15, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense variant p.I124T in NDUFAF6 (NM_152416.4) has been reported previously in patients affected with mitochondrial disease in compound heterozygous state (Kohda M, et al). It has been submitted to ClinVar as Variant of uncertain significance. The variant has been detected in homozygous state in two affected siblings with Leigh disease within one of the submitting labs in ClinVar. The p.I124T missense variant is predicted to be damaging by both SIFT and PolyPhen2. The nucleotide c.371 in NDUFAF6 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. - |
Leigh syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 14, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Uncertain significance, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Dec 03, 2018 | The homozygous p.Ile124Thr variant in NDUFAF6 was identified by our study in two siblings with Leigh syndrome. The p.Ile124Thr variant in NDUFAF6 has been reported in 2 Japanese individuals with Leigh syndrome (PMID: 26741492) and has been identified in 0.07952% (15/18862) of East Asian chromosomes and 0.01949% (6/30780) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs201732170). This variant has also been reported as a VUS in ClinVar (Variation ID: 214212). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The presence of this variant in combination with 2 variants reported pathogenic in the literature and OMIM and in 2 individuals with Leigh syndrome increases the likelihood that the p.Ile124Thr variant is pathogenic. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2, PM3 (Richards 2015). - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 28, 2023 | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 124 of the NDUFAF6 protein (p.Ile124Thr). This variant is present in population databases (rs201732170, gnomAD 0.08%). This missense change has been observed in individuals with clinical features of mitochondrial complex I deficiency (PMID: 26741492, 30642748, 31967322, 32348839). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 214212). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NDUFAF6 protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 12, 2015 | p.Ile124Thr (ATA>ACA): c.371 T>C in exon 3 of the C8ORF38 gene (NM_152416.2). The I128T variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The I128T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. A missense mutation in a nearby residue (D127N) has been reported in association with complex I deficiency, supporting the functional importance of this region of the protein. However, this substitution occurs at a position that is not highly conserved across species and in silico analysis predicts this variant likely does not alter the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in LSME-MITOP,MITONUC-MITOP panel(s). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;T;T;D;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;.;.;.;L;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;D;N;D;D;N
REVEL
Uncertain
Sift
Benign
T;T;T;T;T;T
Sift4G
Benign
T;T;T;T;T;T
Polyphen
0.26
.;.;.;.;B;.
Vest4
0.83, 0.83, 0.85
MVP
MPC
0.33
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at